Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/10/30/2971630/0/en/Noema-Pharma-Announces-First-Patients-Dosed-in-Phase-2b-Study-with-Gemlapodect-NOE-105-a-First-In-Class-Investigational-Therapy-for-Tourette-Syndrome.html

GLOBENEWSWIRE
30 Oct 2024